Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J7FJ
|
||||
Former ID |
DNC013512
|
||||
Drug Name |
1-(5-fluorooxazol-2-yl)-7-phenylheptan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529193] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H18FNO2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=C(O2)F
|
||||
InChI |
1S/C16H18FNO2/c17-15-12-18-16(20-15)14(19)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2
|
||||
InChIKey |
KUKHXFUDITXZRG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529193] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.